Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout

China’s Fosun Pharma to bypass India’s regulatory hurdles after cutting stake in Gland Pharma deal

Name: SCMP
Telephone: +852-2680-8888

Chinese drug maker to cut the stake it wants to buy in India’s Gland Pharma to ensure faster regulatory approvals

Published: 1:00pm, 18 Sep, 2017

Updated: 2:55pm, 20 Jul, 2018

Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout

READ FULL ARTICLE